What is Rapport Therapeutics, Inc.'s capex?

Rapport Therapeutics, Inc. (RAPP) reported capex of $86K in Q1 2026.

How has Rapport Therapeutics, Inc.'s capex changed year-over-year?

Rapport Therapeutics, Inc.'s capex decreased by 70.4% year-over-year, from $291K to $86K.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Rapport Therapeutics, Inc. RAPP CapEx

CapEx at other companies

Bristol-Myers SquibbBMY

$347M+33.5%

Supernus PharmaceuticalsSUPN

$0-100%

Xenon PharmaceuticalsXENE

$133K+209%

Praxis Precision Medicines, Inc.PRAX

$62K—

BiohavenBHVN

$0-100%

Septerna, Inc.SEPN

$832K+118%

Other financials

Income statement

See full

Revenue$20.0M—

Operating income-$24.2M+10.7%

Net income-$19.9M+17.5%

EPS (diluted)-$0.42+38.2%

Balance sheet

See full

Cash & equivalents$78.1M+35.5%

Total debt$10.8M+37.8%

Total equity$471.5M+65.0%

Total assets$497.6M+64.7%

Cash flow

See full

Operating cash flow-$13.1M+35.5%

Free cash flow-$13.1M+36.0%

Valuation

See full

Market cap$1.86B+309%

Enterprise value$1.79B+352%

Returns & leverage

See full

Return on equity-28.3%—

Debt / equity0×0.0×

Current ratio27.1×-3.9×

Where this comes from

Reported directly by Rapport Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapport Therapeutics, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Rapport Therapeutics, Inc.'s capex?: Rapport Therapeutics, Inc. (RAPP) reported capex of $86K in Q1 2026.
How has Rapport Therapeutics, Inc.'s capex changed year-over-year?: Rapport Therapeutics, Inc.'s capex decreased by 70.4% year-over-year, from $291K to $86K.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.